Fig. 1
From: Drug development in Alzheimer’s disease: the path to 2025
Current timeline for clinical development of disease-modifying drugs for approval by 2025 [8]
Fig. 1 | Alzheimer's Research & Therapy
From: Drug development in Alzheimer’s disease: the path to 2025
Current timeline for clinical development of disease-modifying drugs for approval by 2025 [8]
Alzheimer's Research & Therapy